Thank you for standing by, and welcome to the agilon health meeting. During this meeting and the Q&A session that will follow, the company may make forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, which are based on management's current expectations and which are subject to risks, uncertainties, and changes in circumstances. Please see the company's annual report on Form 10-K for the year ended December 31st, 2025, for a description of the risks and uncertainties associated with the company's business, as well as the company's quarterly report on Form 10-Q for the quarter ended March 31st, 2026, as filed with the SEC on May 6th, 2026. These documents contain and identify important factors that could cause actual results to differ materially from those contained in the company's projections or forward-looking statements. Good afternoon, ladies and gentlemen. I am Ron Williams, Chairman of the Board of Directors of agilon health. Welcome to our 2026 annual meeting of stockholders. I will serve as chair of today's meeting. On behalf of the board, I'd like to open this meeting with our commitment to creating long-term value for all of our stakeholders. As a board, we understand true success is a result of a shared vision, strategic engagement with management, and focused execution. Our engagement with the leadership team has focused on working to clarify and sharpen strategic priorities, improving operational execution, and ensuring the right capabilities are in place to deliver sustainable results through our model. In 2025, we made meaningful progress across all of our initiatives, which has translated into strong first quarter 2026 performance and increased expectations for our full year 2026 outlook. The board remains fully aligned with management and will continue to provide guidance, ask difficult questions, and support action where needed. It is my pleasure to now introduce you to agilon health's Chief Executive Officer, Tim O'Rourke. Tim brings significant experience across the payer and provider space, and we are confident he will be instrumental in furthering our mission, strategy, and execution. Tim, who is also a member of our board of directors, will now make comments. Thank you, Ron, and welcome everyone. I'd like to make a few introductions before handing things over to our Chief Legal Officer and Corporate Secretary, Denise Zamore, who will take us through the formal portion of the meeting. First, I'd like to welcome the members of our board of directors joining us today. I would also like to acknowledge the members of the management team who are here with us today, including Jeff Schwaneke, our Chief Financial Officer, Denise Zamore, our Chief Legal Officer and Corporate Secretary, and Evan Smith, our Senior Vice President of Investor Relations. I would also like to introduce Brandon Eggleston, representing Ernst & Young LLP, our independent registered public accounting firm, Andra Troy, representing O'Melveny & Myers, our outside corporate counsel, and Wendy Shiba, engaged by Broadridge Financial Solutions, acting as the independent inspector of election for today's meeting. Now I will turn the meeting over to Denise. Thank you, Tim. In case of technical issues, stockholders may call the technical support number provided on the login page of the virtual stockholder meeting site. We will now conduct the formal part of the meeting. The meeting will now officially come to order. The polls for each matter to be voted on at this meeting are open. The rules of meeting for today's meeting are available on the Virtual Stockholder Meeting or VSM platform. We have verified that notice of this annual meeting was duly given and that the proxy materials for the notice of internet access and availability were mailed on or about April 22nd, 2026, to all stockholders of record on the record date, which was April 8th, 2026. The affidavit of mailing from Broadridge Financial Solutions, Inc., together with copies of the meeting materials, will be filed with the meeting minutes. Wendy Shiba, engaged by Broadridge Financial Solutions, has been appointed the Inspector of Election for the meeting. She has signed an oath of Inspector of Election, promising to execute faithfully the duties of the Inspector of Election, which will be filed with the meeting minutes. The Inspector of Election has determined that a sufficient number of shares entitled to vote at this meeting are present, virtually or by proxy, to constitute a quorum. Stockholders attending the meeting virtually may vote their shares online in real-time for each proposal until the polls are closed. If you have already submitted a proxy to vote your shares, you do not need to vote again online unless you want to change your prior vote. If you are eligible to vote and have not submitted your proxy, or if you want to change your vote, please follow the instructions provided online in the VSM platform. The proposals to be voted on at this meeting are described in the proxy materials that were sent to all stockholders. After we complete the formal meeting, we will adjourn the meeting, and there will be an opportunity for stockholders to ask appropriate general questions through the VSM platform. As a reminder, we ask that any comments or questions during this portion of the meeting pertain only to this meeting or our business in accordance with the rules of meeting posted on the VSM platform. First item of business. The first item of business is proposal one in the proxy statement, the election of the three Class II directors. Each of the following individuals are nominated for a three-year term to serve as Class II directors until our 2029 annual meeting or until their successors are duly elected. First, Diana McKenzie. Second, Karen McLoughlin. Third, Ronald Williams. Our board of directors recommends that stockholders vote in favor of these nominees, and if not otherwise instructed, the proxies solicited by our board will be voted in favor of these nominees. The second item of business is proposal two in the proxy statement to ratify the appointment of Ernst & Young as our independent registered public accountants for the fiscal year ending December 31st, 2026. Our board of directors recommends that stockholders vote in favor of this proposal, and if not otherwise instructed, the proxy solicited by our board will be voted in favor of this proposal. The third item of business is proposal three in the proxy statement. To approve on a non-binding advisory basis the compensation of our named executive officers as disclosed in our proxy statement for the 2026 annual meeting of stockholders. Our board of directors recommends that stockholders vote in favor of this proposal, and if not otherwise instructed, the proxies solicited by our board will be voted in favor of this proposal. Are there any questions on any of the proposals? Your questions at this time should be limited to the specific proposals before today's meeting. We will have a general Q&A session after adjournment of the formal part of this meeting. Next to our online voting, the report of results. If you are voting on proposals one, two, or three, you must submit your votes online at this time in order for them to be counted. The online polls for proposals one, two, and three are now closed. No additional votes and no changes or revocations will be accepted. At this time, I will provide you with a preliminary report on the voting results for proposals one, two, and three as provided to me by the Inspector of Election. Regarding proposal one, the election of directors, Diana McKenzie, Karen McLoughlin, and Ronald Williams have each been reelected to our board of directors to serve as Class II directors for three-year terms until the 2029 annual meeting. Proposal number two, the ratification of Ernst & Young LLP, as the company's independent registered public accounting firm for the fiscal year ending December 31st, 2026, has been ratified and approved. Proposal number three, the non-binding advisory vote regarding the compensation of our named executive officers, has been approved. These are the preliminary results of voting. The final votes, including any votes cast during this meeting, will be reported on a Form 8-K we will file with the Securities and Exchange Commission within the next four days. The formal portion of this annual meeting of stockholders is now adjourned. Thank you for your attendance. We will now proceed with the question and answer portion of the meeting in accordance with the rules of meeting posted on the virtual stockholder meeting platform. Questions should relate to the business of the meeting or the company's business and will be addressed in accordance with the rules of meeting. Evan Smith, our Senior Vice President of Investor Relations, will read the questions. Evan, are there any questions from our stockholders? We did not receive any questions appropriate for this forum under the rules of the meeting. I'll turn it back over to Tim. I want to thank all of you for attending today's meeting and the interest you've shown in agilon health. We very much appreciate your attendance and truly thank you for your support. This concludes today's meeting. You may now disconnect.